Medical device and life science development group Sunrise Labs said this week that it completed its succession plan, with president Eric Soederberg acquiring the majority of shares in the company through a stock sale with founder and board chair Drew Sunstein. With the transaction, the Bedford, N.H.-based company said that it secured its planned ownership […]
IlluminOss Medical Inc.
The FDA last month granted de novo clearance to the photodynamic bone stabilization system developed by IlluminOss Medical. The IlluminOss device uses a light-curable polymer, delivered in an expandable balloon catheter, to stabilize bone fractures. In a Dec. 19 letter to the East Providence, R.I.-based company, the FDA granted de novo clearance for an indication for […]
IlluminOss Medical raised $5 million in a new round of equity financing and looks to raise another $20 million, according to an SEC filing posted today. The offering was made to cover the purchase of the company’s Series AA preferred stock and the exchange of shares of the company’s Series A, B and C1 preferred stocks […]
IlluminOss Medical said today it picked ex-OmniGuide sales & marketing veep Manny Avila as its new chief exec. Prior to his time as sales & marketing veep with OmniGuide, Avila served as veep of commercial operations and surgical solutions in Europe for Covidien, and had management roles at Aspect Medical, Synthes Inc. and Haemonetics (NYSE:HAE), IlluminOss […]
IlluminOss Medical said the FDA granted "conditional" clearance for a clinical trial of its photodynamic bone stabilization system, ahead of its bid for de novo clearance from the watchdog agency.
The medical device industry isn’t being left behind when it comes to angel investing, according to data provided to MassDevice.com from the investment data firm CB Insights.
Angel- and seed-round financing (typically $1.5 million or less) jumped dramatically in 2012, accounting for about 27% of all investment in the medical device industry. That’s a 50% increase compared with 2011.
IlluminOSS Medical, an early-stage medical device company that’s developing a minimally invasive internal fixation system for hand, wrist, clavicle and arm fractures raised $28 million from a syndicate of investors.
MassDevice asks the CEOs of Zoll Medical, Semprus Biosciences, IlluminOss Medical and Good Start Genetics what keeps them up at night at the 2011 MassDevice.com Big 100 Roundtable East.